Remap Consulting provides an integrated approach to pharmaceutical pricing & market access solutions.
We are a specialist pricing, reimbursement and market access consultancy offering an integrated, evidence-based approach to optimising market access. Our strength lies in our ability to understand the market access challenges from your perspective and to develop payer-focused solutions tailored to your business needs.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
White Papers and Resources | March 1, 2019 | Inizio
In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,...
Videos and Podcasts | February 28, 2019 | Lucid Group Communications Limited
Teams from all companies within the Lucid Group and Bluedog gathered to celebrate both the launch of this new partnership and Lucid Group’s twelve-year anniversary. 2019 is set to be a...
Press Releases | February 28, 2019 | Porterhouse Medical Group
An interview with Debbie, office manager at Porterhouse Medical, on what it’s like to live with the rare disease, PSC. Read more ...
White Papers and Resources | February 28, 2019 | Cuttsy + Cuttsy
Today is #RareDiseaseDay and is an opportunity to highlight some truly unbelievable/frightening statistics around rare diseases.
White Papers and Resources | February 25, 2019 | Cuttsy + Cuttsy
If a patient was given their results directly, how could we make it into something they could understand and, most importantly, act on?
Press Releases | February 25, 2019 | Apex Events and Exhibitions
When it comes to exhibition success, pharma companies have lots of things to consider. This includes making sure that you have quality pharma exhibition stands that sparks conversations. But, to...
White Papers and Resources | February 20, 2019 | Blue Latitude Health
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.
Press Releases | February 19, 2019 | Porterhouse Medical Group
Porterhouse Medical is thrilled to announce two further promotions within our scientific and client services teams this month, and would like to congratulate the delightful duo, Alice Wright and Rose Rickman.Alice has been...
White Papers and Resources | February 18, 2019 | Page & Page Health
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space.
White Papers and Resources | February 18, 2019 | Blue Latitude Health
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.